from SERVA Electrophoresis (Heidelberg, Germany).
3,4,5-trimethoxybenzoic acid 8-(diethylamino)
octyl ester (TMB-8, Sigma-Aldrich,
Canada), A23187 (Santa Cruz Biotechnology,
USA), Rottlerin Tumor necrosis factor-alpha
(TNF-α)protease inhibitor I (TAPI-1), U73122,
R59022 (Merck Millipore, USA), and pyrrolidinedithiocarbamate
(PDTC, BioVision, USA)
were employed to investigate the intracellular
signal transduction pathways involved in IL-10
mRNA expression. The actions of these reagents
are summarized in table 1.
In addition, PKC inhibitors including Ro-
318425 (Merck Millipore), Go 6976, Go 6983,
and CGP 41251 (Tocris Bioscience, UK), as
well as a PKC theta/delta inhibitor (Merck Millipore)
were utilized to investigate the roles of
PKC isoforms in IL-10 production. The PKC
isoform-specific inhibition profile of these reagents
is summarized in table 2.
Xestospongin C, which antagonizes the calciumreleasing
action of IP3 at the receptor level, was
obtained from Sigma-Aldrich, USA. Each reagent
solution was negative for endotoxin according to
the Endospecy test (22 (link), 23 (link)).